NKTR
Nektar Therapeutics
$38.12
+$0.79(+2.12%)
47
Overall
40
Value
45
Tech
57
Quality
Market Cap
$1.20B
Volume
590.59K
52W Range
$6.45 - $66.92
Target Price
$114.43
EPS Estimates Overview
| Current Quarter | $-2.69 | Next Quarter | $-2.32 |
| Current Year | $-10.64 | Next Year | $-10.75 |
| QoQ Growth | +13.8% | YoY Growth | -1.0% |
| 3Y EPS CAGR | +76.2% | Target Price | $114.43 |
| Consensus | Buy | Upside | +200.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $38.12 | +2.1% | 590.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |